Linked Life Data

18823859

Source:http://linkedlifedata.com/resource/pubmed/id/18823859

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-9-30
pubmed:abstractText
Because of high rates of trimethoprim-sulfamethoxazole resistance in Escherichia coli, Denver Health switched to levofloxacin as the initial therapy for urinary tract infections (UTIs) in 1999. We evaluated the effects of that switch 6 years later.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1555-7162
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
876-84
pubmed:dateRevised
2010-3-10
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
pubmed:affiliation
University of Denver and Department of Patient Safety and Quality, Denver Health and Hospital Authority, Denver, Colo., USA.
pubmed:publicationType
Journal Article